TipRanks
55% OFF
PC:VWAVE

V-Wave

15 Halamish St. Caesarea, Israel 3079579, ILhttps://vwavemedical.com/

V-Wave is a medical device company developing a transcatheter interatrial shunt system intended to partially decompress the left atrium in patients with heart failure to reduce pulmonary congestion and symptomatic burden. The company focuses on percutaneous implantation of a restrictive interatrial shunt and conducts clinical development programs and regulatory interactions to evaluate the device's safety and performance in heart failure populations.

Leadership & Board

Current Number of Employees
35
Current LinkedIn Followers
6,224

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$98M
Total Funding Rounds
1
Latest Funding Amount
$98M
Latest Funding Round
Series C
Post-Money Valuation
―

Employee Trend

V-Wave had 35 employees as of October 12, 2026. The number of employees decreased by 1 (2.78%) week-over-week.

35Latest Employee Count
1(-2.78%)Week-Over-Week Change
020406080Feb 10, 2026Feb 23, 2026Mar 09, 2026Mar 23, 2026Apr 06, 2026Apr 27, 2026May 11, 2026May 25, 2026Jun 08, 2026Jun 22, 2026Jul 06, 2026Jul 27, 2026Aug 10, 2026Aug 24, 2026Sep 07, 2026Sep 21, 2026Oct 05, 2026

Social Trend

V-Wave had 6,224 followers as of October 12, 2026. The number of followers increased by 5 (0.08%) week-over-week.

6,224Latest Followers Count
5(0.08%)Week-Over-Week Change
02,0004,0006,0008,000Feb 10, 2026Feb 23, 2026Mar 09, 2026Mar 23, 2026Apr 06, 2026Apr 27, 2026May 11, 2026May 25, 2026Jun 08, 2026Jun 22, 2026Jul 06, 2026Jul 27, 2026Aug 10, 2026Aug 24, 2026Sep 07, 2026Sep 21, 2026Oct 05, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jan 16, 2022Series C$98.00M―

Investors

Investor NameFunding Round
DeerfieldSeries C

Related News and Analysis